Stevens Johnson Syndrome associated with Lamotrigine

Area of Science:

• Pharmacology
• Immunology
• Dermatology

Background:

• Stevens-Johnson Syndrome (SJS) is a severe, immune-complex-mediated hypersensitivity reaction.
• It is a known adverse effect associated with various medications.
• Lamotrigine, an anticonvulsant and mood stabilizer, is increasingly used in psychiatric practice.

Observation:

• A patient developed Stevens-Johnson Syndrome (SJS) three weeks after initiating lamotrigine therapy.
• This adverse reaction, though not commonly reported with lamotrigine, carries significant mortality and morbidity.

Findings:

• The case demonstrates a potential link between lamotrigine use and the development of SJS.
• The temporal relationship suggests lamotrigine as a possible causative agent.

Implications:

• Clinicians should exercise caution and maintain a high index of suspicion for SJS in patients taking lamotrigine.
• Increased awareness is crucial given the rising prescription rates of lamotrigine in psychiatric settings.
• Early recognition and management of SJS are vital to mitigate its severe consequences.